Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP662367.RAZZM11c6-yYk3dY_ZsfqyHEPpCkBBCiO7gYCsIpeUkPU130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662367.RAZZM11c6-yYk3dY_ZsfqyHEPpCkBBCiO7gYCsIpeUkPU130_provenance.
• NP420973.RACoUKZXSDJuPwOEZq_SRAQORertB9uvPQmYAwyeF3UYA130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420973.RACoUKZXSDJuPwOEZq_SRAQORertB9uvPQmYAwyeF3UYA130_provenance.
• assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_provenance.
• NP839548.RAZeRYr1GiqYdjMpaBAiuHN19-tttAeO2TtMADt0KGgvk130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839548.RAZeRYr1GiqYdjMpaBAiuHN19-tttAeO2TtMADt0KGgvk130_provenance.
• NP821000.RAQBqRdkoBHMhFHPc85bKQtoP3f-ai84l0gNtxkhtx8a4130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821000.RAQBqRdkoBHMhFHPc85bKQtoP3f-ai84l0gNtxkhtx8a4130_provenance.
• assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
• NP324286.RAXKXh_xH3aN4l-awIMb4VWh3zTXex0W20TWnkCO8vX88130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324286.RAXKXh_xH3aN4l-awIMb4VWh3zTXex0W20TWnkCO8vX88130_provenance.
• NP609995.RAhGPEGFBZFe1SIXn4l-nBUhZLK3uHplklDJB-kjXPj1Q130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609995.RAhGPEGFBZFe1SIXn4l-nBUhZLK3uHplklDJB-kjXPj1Q130_provenance.
• NP324287.RArjvxwLi2GxmXp-GTAE4fz374YICQEa0WFXnZHD27a2A130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324287.RArjvxwLi2GxmXp-GTAE4fz374YICQEa0WFXnZHD27a2A130_provenance.
• NP252311.RA7_gI0TivutEXf7MSfZkxb5J9eBOgM9mo39WZcf7sy1g130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252311.RA7_gI0TivutEXf7MSfZkxb5J9eBOgM9mo39WZcf7sy1g130_provenance.
• NP623357.RA3U9c9xbSaJv2sXCJRAg5P7_tFCmhjjVbk4mxeE1KT2c130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623357.RA3U9c9xbSaJv2sXCJRAg5P7_tFCmhjjVbk4mxeE1KT2c130_provenance.
• NP324285.RAMnWRUXtSl8OcyA16W_oaMzc3jNKph7y_7zbJZCrsaYI130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324285.RAMnWRUXtSl8OcyA16W_oaMzc3jNKph7y_7zbJZCrsaYI130_provenance.
• NP324284.RA_-r7HL0INc9Oic8drFOwtWdOZ9OOr-oPMLqwuyVIlHM130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324284.RA_-r7HL0INc9Oic8drFOwtWdOZ9OOr-oPMLqwuyVIlHM130_provenance.